2100 WHARTON STREET, PITTSBURGH, PA
Krystal Biotech Elects Class III Directors at 2026 Annual Meeting
Annual Report to Security Holders
Announces Fourth Quarter and Full Year 2025 Financial and Operating Results
Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
Investor Presentation
Director Resignation - Kirti Ganorkar Steps Down from Board
Announces Third Quarter 2025 Financial and Operating Results
Q1
FY 2024
Q3
Q2
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus Filed Pursuant to Rule 424(b)(2)
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Submission Upload
Correspondence
S-1MEF